Skip to main content

Warning issued over unusual increase in RSV cases - Cleveland 19 News

LORAIN COUNTY, Ohio (WOIO) - Parents are being advised about a rare summertime rise in respiratory syncytial virus (RSV) cases throughout Northeast Ohio.

RSV is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious, especially for infants and older adults.

Killian McCall, 4, is still dealing with issues caused by the severe cause of RSV he had when he was a year old.

"It actually ended up being pretty bad, they put him in the emergency room," said Benjamin McCall, Killian's father. "At the time, my son was breathing about 60 times per minute. He did end up on several inhalers and he still has asthma now as a result of it."

RSV is the most common cause of bronchiolitis (inflammation of the small airways in the lung) and pneumonia (infection of the lungs) in children younger than 1 year of age in the United States, according to the Centers for Disease Control and Prevention.

RSV cases are most often seen in the fall and winter, but an unusual uptick in cases is happening right now in places like Lorain County.

"It's important for parents to realize, that it's out there," said Dave Kovell, the health commissioner for Lorain County.

This rare increase in cases being seen not just here in Lorain County, but all over the country.

Last week, the CDC reported over 1600 cases of RSV, nationwide. This time last year, there were just 12 reported cases.

So why are we seeing more cases right now?

"There's some discussion of as children have worn masks and stayed away from other kids you know you don't get the spread of normal diseases," Kovell told 19 News.

Symptoms include fast breathing or difficulty breathing or trouble swallowing liquids.

"You'll know that it's not just a normal cold because they don't feel like getting up they don't feel like moving around," said McCall.

Kovell advises parents to contact their doctors if you start to see symptoms in your child

"It may be COVID-19 but it's probably more likely RSV," Kovell said.

Copyright 2021 WOIO. All rights reserved.

Adblock test (Why?)

Comments

Post a Comment

Popular posts from this blog

Epoprostenol Via High-Flow Nasal Cannula Improves Severe Hypoxemia in PH - Pulmonology Advisor

Image
Epoprostenol Via High-Flow Nasal Cannula Improves Severe Hypoxemia in PH - Pulmonology Advisor Epoprostenol Via High-Flow Nasal Cannula Improves Severe Hypoxemia in PH - Pulmonology Advisor Posted: 11 Jul 2019 12:00 AM PDT For patients with severe hypoxemia with pulmonary hypertension or right heart dysfunction, inhaled epoprostenol through high-flow nasal cannula increases oxygenation, according to a study published in Pharmaceutics . The researchers of this retrospective study assessed the effect of inhaled epoprostenol using a high-flow nasal cannula on oxygenation and future mechanical ventilation in patients with hypoxemia comorbid with pulmonary hypertension or right heart dysfunction in an intensive care unit setting. A chart review was completed on adult patients who were admitted into the respiratory care department of the Rush University Medical Center for severe hypoxemia between July 2015 and April 2018 and treated with inha...
Read more

Novitium's Generic Sildenafil for PAH Treatment Approved by FDA - Pulmonary Hypertension News

Image
Novitium's Generic Sildenafil for PAH Treatment Approved by FDA - Pulmonary Hypertension News Novitium's Generic Sildenafil for PAH Treatment Approved by FDA - Pulmonary Hypertension News Growing Doubt, Uncertainty Over PDE5i Use in Left Heart Disease - Medscape AnMed Health gains national recognition through the Pulmonary Hypertension Association - WSPA.com Novitium's Generic Sildenafil for PAH Treatment Approved by FDA - Pulmonary Hypertension News Posted: 12 Jun 2019 05:00 AM PDT The U.S. Food and Drug Administration (FDA) has approved Novitium Pharma 's generic sildenafil for oral suspension at a dose of 10 mg/mL for the treatment of pulmonary arterial hypertension (PAH). This product, which had been designated a competitive generic therapy by the FDA, is the first approved generic equivalent to Pfizer 's Revatio , a vasodilator agent that induces blood ves...
Read more

Analysis: Large pharma companies do little new drug innovation - STAT

Image
Analysis: Large pharma companies do little new drug innovation - STAT Analysis: Large pharma companies do little new drug innovation - STAT Gene Therapy Takes Center Stage at 2019 NORD Summit - Pulmonary Hypertension News People Living With Type 2 Diabetes Want Information and Empathy From Their Doctors More Than New Medications - PRNewswire Analysis: Large pharma companies do little new drug innovation - STAT Posted: 10 Dec 2019 01:51 AM PST L arge pharmaceutical companies oppose legislation being considered by Congress to lower the prices of prescription drugs. Reducing their revenues, they contend, will reduce their investment in drug development and the discovery of new medicines, and thus lead to a decline in drug innovation. If that argument is credible, there should be evidence to show that the large pharmaceutical companies are responsible for discovering innovative new drugs. To test that claim, we examined the...
Read more